Identification of Early Growth Response Gene-1 (Egr-1) as a Phorbol Myristate Acetate-induced Gene in Lung Cancer Cells by Differential mRNA Display

American Journal of Respiratory Cell and Molecular Biology

Volumn 17, Issue 5, 1997, Pages 617-624

  You, Liang ^a   Jakowlew, Sonia B ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; DNA BINDING PROTEIN; EARLY GROWTH RESPONSE FACTOR 1; EGR1 PROTEIN, HUMAN; IMMEDIATE EARLY PROTEIN; MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE; TRANSCRIPTION FACTOR;

ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOLOGY;

BASE SEQUENCE; CARCINOGENS; CARCINOMA, NON-SMALL-CELL LUNG; CELL DIFFERENTIATION; DNA-BINDING PROTEINS; EARLY GROWTH RESPONSE PROTEIN 1; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMEDIATE-EARLY PROTEINS; LUNG NEOPLASMS; MOLECULAR SEQUENCE DATA; RNA, MESSENGER; TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0031279396     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.17.5.2843     Document Type: Article

References (34)

1. Boring, C. C., T. S. Squires, and T. Tong. 1992. Cancer statistics. CA Cancer J. Clin. 42:19-38.
2. Ginsberg, R. J. 1993. Multimodality therapy for stage IIIA (N2) lung cancer: an overview. Chest 103:356s-359s.
3. Minna, J. D., E. Glatstein, and D. C. Ihde. 1991. Cancer of the lung. In Principles and Practice of Oncology. V. T. Devita, S. Hellman, S. Rosenberg, editors. JB Lippincott, Philadelphia, 591-705.
4. Bishop, J. M. 1991. Molecular themes in oncogenesis. Cell 64:235-248.
5. Hunter, T. 1991. Cooperation between oncogenes. Cell 64:249-270.
6. Curran, T., and B. R. Franza. 1988. Fos and jun: the AP-1 connection. Cell 55:395-397.
7. Angel, P., and M. Karin. 1991. The role of jun, fos, and the AP-1 complex in cell proliferation and transformation. Biochim. Biophys. Acta 1072:129-157.
8. Franzen, P., H. Ichijo, and K. Miyazono. 1993. Different signals mediate transforming growth factor-beta 1-induced growth inhibition and extracellular matrix production in prostate carcinoma cells. Exp. Cell Res. 207:1-7.
9. Weiss, R. H., A. P. Yabes, and R. Sinaee. 1995. TGF-β and phorbol esters inhibit mitogenesis utilizing parallel protein kinase C-dependent pathways. Kidney Inter. 48:738-744.
10. Liang, P., and A. B. Pardee. 1992. Differential display of eukaryotic mRNAs by means of the polymerase chain reaction. Science 257:967-971.
11. Liang, P., W. Zhu, X. Zhang, Z. Guo, R. P. O'Connell, L. Averboukh, F. Wang, and A. B. Pardee. 1994. Differential display using one base anchored oligo-dT primers. Nuc. Acids Res. 22:5763-5764.
12. Carney, D. N., A. F. Gazdar, G. Bepler, J. G. Guccion, P. J. Marangos, T. W. Moody, M. H. Zweig, and J. D. Minna. 1985. Establishment and identification of small cell lung cancer cell lines having classic and variant features. Cancer Res. 45:2913-2923.
13. Lebacq-Verheyden, A. M., P. G. Kasprzyk, M. G. Raum, K. Van Wyke Coelingh, J. A. Lebacq, and J. F. Battey. 1988. Posttranslational processing of endogenous and of baculovirus-expressed human gastrin releasing peptide precursor. Mol. Cell. Biol. 8:3129-3135.
14. Chirgwin, J. M., A. E. Przybla, R. J. MacDonald, and W. J. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294-5299.
15. Church, G. M., and W. Gilbert. 1984. Genomic sequencing. Proc. Natl. Acad. Sci. USA 80:1991-1995.
16. Sukhatme, V. P., S. Kartha, F. G. Toback, R. Taub, R. G. Hoover, and C.-H. Tsai-Morris. 1987. A novel early growth response gene rapidly induced by fibroblast, epithelial cell and lymphocyte mitogens. Oncogene Res. 1:343-355.
17. Sukhatme, V. P., X. Cao, L. C. Chang, C.-H. Tsai-Morris, D. Stamenkovitch, P. C. P. Ferreira, D. R. Cohen, S. A. Edwards, T. B. Shows, T. Curran, M. M. Le Beau, and E. D. Adamson. 1988. A zinc finger-encoding gene coregulated with c-fos during growth and differentiation, and after cellular depolarization. Cell 53:37-43.
18. Curran, T., and N. M. Teich. 1982. Candidate product of the FBJ murine osteosarcoma virus oncogene: characterization of a 55-kilodalton phosphoprotein. J. Virol. 42:114-122.
19. Qian, S. W., P. Kondaiah, A. B. Roberts, and M. B. Sporn. 1990. cDNA cloning by PCR of rat transforming growth factor-β1. Nuc. Acids Res. 18: 7 3059.
20. Draoui, M., P. Chung, M. Park, M. Birrer, S. B. Jakowlew, and T. W. Moody. 1995. Bombesin stimulates c-fos and c-jun mRNAs in small cell lung cancer cells. Peptides 16:289-292.
21. Jakowlew, S. B., J. M. Mariano, and L. You. 1997. Effects of transforming growth facator-β1 and phorbol ester on PAI-1 and PA genes in human lung cells. Growth Factors (In press)
22. Blumberg, P. M. 1991. Complexities of the protein kinase C pathway. Mol. Carcinog. 4:339-344.
23. Dekker, L. V., and P. Parker. 1994. Protein kinase C: a question of specificity. Trends Biochem. 19:72-77.
24. Bohmann, D., T. J. Bos, A. Admon, T. Nishimura, P. K. Vogt, and R. Tjian. 1987. Human proto-oncogene c-jun encodes a DNA binding protein with structural and functional properties of transcription factor AP-1. Science 238:1386-1392.
25. Jakowlew, S. B., A. Mathias, P. Chung, and T. W. Moody. 1995. Expression of transforming growth factor-β ligand and receptor mRNAs in lung cancer cell lines. Cell Growth Diff. 6:465-476.
26. Gashler, A., and V. P. Sukhatme. 1995. Early growth response protein 1 (EGR-1): prototype of a zinc-finger family of transcription factors. Prog. Nuc. Acid Res. Mol. Biol. 50:191-224.
27. Kim, S.-J., A. Glick, M. B. Sporn, and A. B. Roberts. 1989. Characterization of the promoter region of the human transforming growth factor-β1 gene. J. Biol. Chem. 264:402-408.
28. Geiser, A. G., K. J. Busam, S.-J. Kim, R. Lafyatis, M. A. O'Reilly, R. Webbink, A. B. Roberts, and M. B. Sporn. 1993. Regulation of the transforming growth factor-β1 and -β3 promoters by the transcription factor Sp1. Gene 129:223-229.
29. Dey, B. R., V. P. Sukhatme, A. B. Roberts, M. B. Sporn, F. J. Rauscher, III, and S.-J. Kim. 1994. Repression of the transforming growth factor-β1 gene by the Wilms' tumor suppressor WT1 gene product. Mol. Endocrinol. 8: 595-602.
30. Liu, C., E. Adamson, and O. Mercola. 1996. Transcription factor EGR-1 suppresses the growth and transformation of human HT-1080 fibrosarcoma cells by induction of transforming growth factor β1. Proc. Natl. Acad. Sci. USA 93:11831-11836.
31. Wiley, J. C., C. E. Moser, J. F. Lechner, and C. C. Harris. 1984. Differential effects of 12-O-tetradecanoylphorbol-13-acetate on cultured normal and neoplastic human bronchial epithelial cells. Cancer Res. 44:5124-5126.
32. Masui, T., L. M. Wakefield, J. F. Lechner, M. A. LaVeck, M. B. Sporn, and C. C. Harris. 1986. Type β transforming growth factor is the primary differentiation-inducing serum factor for normal human bronchial epithelial cells. Proc. Natl. Acad. Sci. USA 83:2438-2442.
33. Ke, Y., B. I. Gerwin, S. E. Ruskie, A. M. A. Pfeifer, C. C. Harris, and J. F. Lechner. 1990. Cell density governs the ability of human bronchial eptithelial cells to recognize serum and transforming growth factor bela-1 as squamous differentiation-inducing agents. Am. J. Pathol. 137:833-843.
34. Levin, W. J., M. F. Press, R. B. Gaynor, V. P. Sukhatme, T. C. Boone, P. T. Reissmann, R. A. Figlin, E. Carmack Holmes, L. M. Souza, D. J. Slamon and the Lung Cancer Study Group. 1995. Expression patterns of immediate early transcription factors in human non-small cell lung cancer. Oncogene 11:1261-1269.